IPCA MMF 500 Tablet

By MMF

Rx

10 Tablet in a Strip

Composition icon

Composition

Mycophenolate mofetil(500mg)

Manufacturer - Ipca Laboratories Ltd icon

Manufacturer - Ipca Laboratories Ltd

142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after icon

Expires on or after

March, 2026

About IPCA MMF 500 Tablet

IPCA MMF 500 Tablet is a medication classified under the group of medicines known as immunosuppressants. It is commonly prescribed in combination with other medications to prevent the body from rejecting a transplanted organ, such as a kidney, heart, or liver. By suppressing the body's immune system, IPCA MMF 500 Tablet helps to protect the newly transplanted organ from being attacked.

The dosage and frequency of IPCA MMF 500 Tablet intake are determined based on the type of transplant the individual has undergone. It is usually recommended to take the tablet on an empty stomach, at least 1 hour before or 2 hours after a meal, unless advised otherwise by the doctor. It is essential to swallow the tablet whole and not crush, chew, or break it. Consistency in taking the medication is crucial to derive maximum benefits, even when the individual feels well, as the treatment is intended for long-term use to prevent rejection.

Common side effects associated with IPCA MMF 500 Tablet include nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, and changes in the white blood cell count. Due to its immune-suppressing properties, individuals taking this medication may be more susceptible to infections. Moreover, there is an increased risk of developing certain types of cancers. To minimize the risk of skin cancer, it is important to limit exposure to the sun and use sunscreen regularly. It is advisable to consult with a healthcare provider regarding the potential side effects and warning signs that require immediate medical attention.

IPCA MMF 500 Tablet poses risks of birth defects and abortion; therefore, it should not be taken by pregnant individuals, those planning pregnancy, or while breastfeeding. Patients exhibiting signs of infection or unexplained bruising or bleeding should consult their doctor before initiating treatment with IPCA MMF 500 Tablet. Informing the healthcare team about all other medications being taken is crucial as interactions may occur. Regular monitoring through blood tests is necessary to assess changes in blood cell counts, as well as sugar and cholesterol levels in the blood.


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

783.2

Inclusive of all taxes

Content verified by

chevron-right

Dr. Archana Prabhakar

MBBS, M.Med (Family Medicine)

Last update on 07-Oct-2024